Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
{{output}}
Nanobodies, single-domain antibodies derived from variable domain of camelid or shark heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy construction in versatile formats, high neutralizing activity, protective effica... ...